Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Cancer Research|August 3, 2007
Interaction of MLL amino terminal sequences with menin is required for transformationCorrado Caslini, Zhaohai Yang, Mohamad El-Osta, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 22, 2018
Novel Finding of Paired Box 5 (PAX5) Cytoplasmic Staining in Well-differentiated Rectal Neuroendocrine Tumors (Carcinoids) and Its Diagnostic and Potentially Prognostic UtilityZhiyan Fu, Chunlai Zuo, Christine E Sheehan, et al.
Neoplasia (New York, N.Y.)|February 16, 2018
Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR SignalingElizabeth M Matthew, Zhaohai Yang, Suraj Peri, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Paired Box 5 (PAX5) Expression in Poorly Differentiated Neuroendocrine Carcinoma of the Gastrointestinal and Pancreatobiliary Tract: Diagnostic and Potentially Therapeutic ImplicationsSanaz Ainechi, Steven A Mann, Jingmei Lin, et al.
Cancer Biology & Therapy|June 25, 2013
Off-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancerMhd Yaser Al-Marrawi, Bikramajit Singh Saroya, Matthew C Brennan, et al.
Annals of Surgical Oncology|June 13, 2021
Gastric Neuroendocrine Tumors: Reappraisal of Type in Predicting OutcomeAndrew Hanna, Caroline Kim-Kiselak, Rebecca Tang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
Challenges with colorectal cancer staging: results of an international studyDipti M Karamchandani, Runjan Chetty, Tonya S King, et al.
Annals of Diagnostic Pathology|September 22, 2018
The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomasHwajeong Lee, Zhiyan Fu, Brandon H Koo, et al.
Pageof 7